{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:15:01Z","timestamp":1786976101910,"version":"build-2736575974"},"reference-count":61,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100002679","name":"Adnan Menderes \u00dcniversitesi","doi-asserted-by":"publisher","award":["ADU\u2010TPF\u201023045"],"award-info":[{"award-number":["ADU\u2010TPF\u201023045"]}],"id":[{"id":"10.13039\/501100002679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002679","name":"Adnan Menderes \u00dcniversitesi","doi-asserted-by":"publisher","award":["ADU\u2010TPF\u201022033"],"award-info":[{"award-number":["ADU\u2010TPF\u201022033"]}],"id":[{"id":"10.13039\/501100002679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020410","name":"T\u00fcrkiye Sa\u011fl\u0131k Enstit\u00fcleri Ba\u015fkanl\u0131\u011f\u0131","doi-asserted-by":"publisher","award":["TUSEB\u20104381"],"award-info":[{"award-number":["TUSEB\u20104381"]}],"id":[{"id":"10.13039\/100020410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004412","name":"T\u00fcrkiye Bilimler Akademisi","doi-asserted-by":"publisher","award":["TUBA\u2010GEBIP"],"award-info":[{"award-number":["TUBA\u2010GEBIP"]}],"id":[{"id":"10.13039\/501100004412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["febs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Molecular Oncology"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>\n                    Targeted drug therapy is very important for the treatment of triple\u2010negative breast cancer (\n                    <jats:styled-content style=\"fixed-case\">TNBC<\/jats:styled-content>\n                    ), and the development of carrier systems to deliver apoptosis\u2010inducing proteins such as\n                    <jats:styled-content style=\"fixed-case\">TRAIL<\/jats:styled-content>\n                    to cells is important in cancer therapy. In this study, a nanosystem formulation (\n                    <jats:styled-content style=\"fixed-case\">TRAIL<\/jats:styled-content>\n                    \u2010\n                    <jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\n                    \u2010Apt\u2010\n                    <jats:styled-content style=\"fixed-case\">PLGA<\/jats:styled-content>\n                    ) encapsulating\n                    <jats:styled-content style=\"fixed-case\">TNBC<\/jats:styled-content>\n                    \u2010targeted aptamer\u2010bound\u2010\n                    <jats:styled-content style=\"fixed-case\">TRAIL<\/jats:styled-content>\n                    protein was performed and the efficacy of this system was evaluated in a mouse tumor model. The characterization of\n                    <jats:styled-content style=\"fixed-case\">TRAIL<\/jats:styled-content>\n                    \u2010\n                    <jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\n                    \u2010Apt\u2010\n                    <jats:styled-content style=\"fixed-case\">PLGA<\/jats:styled-content>\n                    was confirmed by\n                    <jats:styled-content style=\"fixed-case\">FTIR<\/jats:styled-content>\n                    ,\n                    <jats:styled-content style=\"fixed-case\">NTA<\/jats:styled-content>\n                    and\n                    <jats:styled-content style=\"fixed-case\">SEM<\/jats:styled-content>\n                    microscopy. The efficacy of\n                    <jats:styled-content style=\"fixed-case\">TRAIL<\/jats:styled-content>\n                    \u2010\n                    <jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\n                    \u2010Apt\u2010\n                    <jats:styled-content style=\"fixed-case\">PLGA<\/jats:styled-content>\n                    was evaluated by\n                    <jats:italic>in vitro<\/jats:italic>\n                    release assays and interactions with\n                    <jats:styled-content style=\"fixed-case\">TNBC<\/jats:styled-content>\n                    cells (\n                    <jats:styled-content style=\"fixed-case\">MDA<\/jats:styled-content>\n                    \u2010\n                    <jats:styled-content style=\"fixed-case\">MB<\/jats:styled-content>\n                    \u2010231) and healthy breast cells (\n                    <jats:styled-content style=\"fixed-case\">MCF\u201010A<\/jats:styled-content>\n                    ).\n                    <jats:styled-content style=\"fixed-case\">TRAIL<\/jats:styled-content>\n                    \u2010\n                    <jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\n                    \u2010Apt\u2010\n                    <jats:styled-content style=\"fixed-case\">PLGA<\/jats:styled-content>\n                    was administered intravenously to\n                    <jats:styled-content style=\"fixed-case\">NOD<\/jats:styled-content>\n                    \/\n                    <jats:styled-content style=\"fixed-case\">SCID<\/jats:styled-content>\n                    gamma mouse breast tumors and evaluated\n                    <jats:italic>in vivo<\/jats:italic>\n                    . Pharmacokinetics, bioavailability testing, histological staining (\n                    <jats:styled-content style=\"fixed-case\">DR4<\/jats:styled-content>\n                    \/\n                    <jats:styled-content style=\"fixed-case\">DR5<\/jats:styled-content>\n                    ,\n                    <jats:styled-content style=\"fixed-case\">TUNEL<\/jats:styled-content>\n                    ,\n                    <jats:styled-content style=\"fixed-case\">HE<\/jats:styled-content>\n                    staining) and molecular alterations with\n                    <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>\n                    array were evaluated in tumor tissues.\n                    <jats:styled-content style=\"fixed-case\">TRAIL<\/jats:styled-content>\n                    \u2010\n                    <jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\n                    \u2010Apt\u2010\n                    <jats:styled-content style=\"fixed-case\">PLGA<\/jats:styled-content>\n                    induced apoptosis in both\n                    <jats:italic>in vivo<\/jats:italic>\n                    and\n                    <jats:italic>in vitro<\/jats:italic>\n                    studies. It was found that it regulated cellular responses along with apoptotic mechanisms in cells without developing resistance in suppressing tumor growth by making changes on Atf2, Casp8, Bcl2 and Irf5 genes and proteins. As a result, the biotechnological drug potential of\n                    <jats:styled-content style=\"fixed-case\">TRAIL<\/jats:styled-content>\n                    was discovered in an aptamer\u2010bound nanosystem for the treatment of triple\u2010negative breast cancer and innovative applications for clinical use.\n                  <\/jats:p>","DOI":"10.1002\/1878-0261.70202","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T05:25:21Z","timestamp":1770614721000},"page":"1742-1761","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["<scp>TRAIL<\/scp>\n                    \u2010\n                    <scp>PEG<\/scp>\n                    \u2010Apt\u2010\n                    <scp>PLGA<\/scp>\n                    nanosystem as an aptamer\u2010targeted drug delivery system potential for triple\u2010negative breast cancer therapy using\n                    <i>in vivo<\/i>\n                    mouse model"],"prefix":"10.1002","volume":"20","author":[{"given":"Gulen Melike","family":"Demirbolat","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Technology Faculty of Pharmacy, Acibadem Mehmet Ali Aydinlar University  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslihan","family":"Kucuk","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology Graduate School of Health Sciences, Aydin Adnan Menderes University  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Erdogan","sequence":"additional","affiliation":[{"name":"Department of Medicinal Biochemistry School of Medicine, Gaziantep Islam Science and Technology University  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samed","family":"Ozer","sequence":"additional","affiliation":[{"name":"Animal Application and Research Center Acibadem Mehmet Ali Aydinlar University  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bensu","family":"Kozan","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology Graduate School of Health Sciences, Aydin Adnan Menderes University  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Cuceli","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology Graduate School of Health Sciences, Aydin Adnan Menderes University  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Gumus","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology School of Medicine, Aydin Adnan Menderes University  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evrim","family":"Cevik","sequence":"additional","affiliation":[{"name":"Department of Machine and Metal Technologies Kocarli Vocational School, Aydin Adnan Menderes University  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9325-3757","authenticated-orcid":false,"given":"Ozge","family":"Cevik","sequence":"additional","affiliation":[{"name":"Department of Medicinal Biochemistry School of Medicine, Aydin Adnan Menderes University  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2465"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/nano11020502"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.81"},{"issue":"17","key":"e_1_2_11_5_1","first-page":"5390","article-title":"Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor\u2010related apoptosis\u2010inducing ligand\/Apo\u20102 ligand on apoptosis and on regression of breast carcinoma in vivo","volume":"63","author":"Singh TR","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.CCR\u201009\u20102443"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008\u20105472.CAN\u201004\u20101683"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac062151b"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25136833"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3141"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00996358"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioeng.2007.06.001"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.74"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/am.2014.12"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc200187k"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2010.10.037"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.03.026"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac501205q"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201200178"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S75821"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2006.09.047"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12247\u2010021\u201009539\u20104"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.55730\/1300\u20100527.3411"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.21769\/bioprotoc.3465"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1039\/b702213a"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.15171\/bi.2018.14"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/polym6010093"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230\u2010973x.143112"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.4155\/fsoa\u20102016\u20100030"},{"issue":"1","key":"e_1_2_11_30_1","first-page":"139","article-title":"Role of Nanocarriers for enhancement of drug bioavailability","volume":"10","author":"Sharma AK","year":"2018","journal-title":"J Chem Pharm Res"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.01.054"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2015.02.001"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555\u2010018\u20109728\u2010y"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41420\u2010025\u201002335\u2010w"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1039\/d2ra00940d"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.07.032"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042\u20107158.2012.01564.x"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1316312111"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34359"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.10.050"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051129"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1088\/0957\u20104484\/22\/26\/265105"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.08.055"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122733"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058\u2010020\u201001359\u20107"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.234"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj\/onc\/1205258"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404\u2010013\u20103060\u20100"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M804744200"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.06.001"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.792721"},{"issue":"19","key":"e_1_2_11_52_1","first-page":"6424","article-title":"Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death","volume":"63","author":"Barnes BJ","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/86397"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6926"},{"issue":"5","key":"e_1_2_11_55_1","first-page":"1362","article-title":"Direct stimulation of apoptotic signaling by soluble Apo2l\/tumor necrosis factor\u2010related apoptosis\u2010inducing ligand leads to selective killing of glioma cells","volume":"7","author":"Pollack IF","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/86401"},{"issue":"20","key":"e_1_2_11_57_1","first-page":"5800","article-title":"Effects of tumor necrosis factor\u2010related apoptosis\u2010inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice","volume":"62","author":"Naka T","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102007\u201002\u2010076075"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.628332"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479\u20105876\u20103\u201022"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.1991"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4847"}],"container-title":["Molecular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1878-0261.70202","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/1878-0261.70202","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1878-0261.70202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T07:02:04Z","timestamp":1783839724000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1002\/1878-0261.70202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1002\/1878-0261.70202"],"URL":"https:\/\/doi.org\/10.1002\/1878-0261.70202","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1002\/1878-0261.70202\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/1878-0261.70202\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/1878-0261.70202\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/1878-0261.70202\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/1878-0261.70202\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/1878-0261.70202\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/1878-0261.70202\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/1878-0261.70202\/v3\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/1878-0261.70202\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/1878-0261.70202\/v1\/decision1","asserted-by":"object"}]},"ISSN":["1574-7891","1878-0261"],"issn-type":[{"value":"1574-7891","type":"print"},{"value":"1878-0261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"2025-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}